- Home
- INZY vs PERF Comparison
INZY vs PERF Comparison
Compare INZY & PERF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- PERF
- Stock Information
- Founded
- INZY 2015
- PERF 2015
- Country
- INZY United States
- PERF Taiwan
- Employees
- INZY N/A
- PERF N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- PERF Computer Software: Prepackaged Software
- Sector
- INZY Health Care
- PERF Technology
- Exchange
- INZY Nasdaq
- PERF Nasdaq
- Market Cap
- INZY 165.1M
- PERF 197.6M
- IPO Year
- INZY 2020
- PERF N/A
- Fundamental
- Price
- INZY $2.73
- PERF $2.20
- Analyst Decision
- INZY Strong Buy
- PERF Buy
- Analyst Count
- INZY 7
- PERF 2
- Target Price
- INZY $16.14
- PERF $4.00
- AVG Volume (30 Days)
- INZY 885.2K
- PERF 140.0K
- Earning Date
- INZY 11-05-2024
- PERF 10-29-2024
- Dividend Yield
- INZY N/A
- PERF N/A
- EPS Growth
- INZY N/A
- PERF N/A
- EPS
- INZY N/A
- PERF 0.05
- Revenue
- INZY N/A
- PERF $58,445,000.00
- Revenue This Year
- INZY N/A
- PERF $15.44
- Revenue Next Year
- INZY N/A
- PERF $13.52
- P/E Ratio
- INZY N/A
- PERF $41.97
- Revenue Growth
- INZY N/A
- PERF 15.84
- 52 Week Low
- INZY $2.39
- PERF $1.70
- 52 Week High
- INZY $7.80
- PERF $3.77
- Technical
- Relative Strength Index (RSI)
- INZY 41.48
- PERF 57.35
- Support Level
- INZY $2.84
- PERF $2.22
- Resistance Level
- INZY $3.28
- PERF $2.57
- Average True Range (ATR)
- INZY 0.25
- PERF 0.27
- MACD
- INZY 0.10
- PERF -0.01
- Stochastic Oscillator
- INZY 48.84
- PERF 50.01
About INZY Inozyme Pharma Inc.
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.
About PERF Perfect Corp.
Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions that are ultra-personalized, interactive and engaging, from online to in-store through beauty mirrors. Geographically, the company has a presence in the United States, France, Japan and Others.